HONOLULU, HI—Intravenous(IV) prochlorperazine is more effective for the acute treatment of refractorymigraine in pediatric patients than IV metoclopramide or valproate sodium. ShannonCherney, MSN, CNP ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a New Jersey-based pharmaceutical company, today announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Prochlorperazine Edisylate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback